entity

Survival

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Survival: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11Connections
1Hypotheses
4Analyses
0Outgoing
11Incoming
1Experiments
4Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Corticobasal Syndrome (CBS)

disease · 11374 words

Novel Therapy Index

idea · 10647 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (11)

SourceRelationTypeStr
Serum NfLassociated_withbiomarker0.90
Trastuzumab Deruxtecanpromotesdrug0.90
Nflcorrelates_withbiomarker0.90
ANXA1biomarker_forprotein0.88
ANXA1 Expressioncorrelates_withbiomarker0.85

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Heterogeneous astrocyte activation states differentially imp 0.640 Alzheimer's disease SEA-AD Single-Cell Analysis: Cell-Type V

Mentioning Analyses (4)

Scientific analyses that reference this entity

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

neurodegeneration | 2026-04-16 | 2 hypotheses Top: 0.778

Which metabolic biomarkers can distinguish therapeutic response from disease pro

translational neuroscience | 2026-04-04 | 7 hypotheses Top: 0.803

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

neurodegeneration | 2026-04-04 | 0 hypotheses

Metabolic reprogramming in neurodegenerative disease

neurodegeneration | 2026-04-02 | 3 hypotheses Top: 0.652

Experiments (1)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
iPSC-NPC effects on astrocytes in vitro ICH model exploratory intracerebral hemorrhage 0.900 0.00 in vitro ICH cell culture mode proposed N/A

Related Papers (12)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Brain atrophy patterns in anti-IgLON5 disease. [PMID:40650880] Yogeshwar SM, Bartels F, Grüter T, Muñiz Brain 2026 0
Potential diagnostic markers in Alzheimer's disease: current perspectives and fu [PMID:40911035] Zheng M, Wang S, Jia J Neurodegener Dis Manag 2026 0
Kidney Function, Alzheimer Disease Blood Biomarkers, and Dementia Risk in Commun [PMID:41337685] Gasparini F, Valletta M, Vetrano DL, Ber Neurology 2026 0
Impaired glymphatic function is associated with synaptic loss in cognitive impai [PMID:41454064] Unknown European journal of nuclear me 2026 0
The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and [PMID:41527736] Abedin MJ, Kastanenka KV J Alzheimers Dis 2026 0
Biomarker-integrated prognostic stagings for Alzheimer's Disease. [PMID:41622252] Shin D, Lee S, Kim JP, Jang H, Yun J et Nat Commun 2026 0
Prognostic Value of Plasma NfL and GFAP for Conversion to Alzheimer's Disease an [PMID:41703957] Özkurt Ç, Kelicen-Uğur P Biomarkers 2026 0
Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] ["Aranda-Abreu GE", "Rojas-Dur\u00e1n F" Neurol Int 2026 0
From scaffold to effector: reframing GFAP in neurodegeneration. [PMID:41775321] Lu YH, Zhu XP, Li S, Zhang FN, Cai CB et J Adv Res 2026 0
Translating neurofilament light chain testing into clinical practice: a multidis [PMID:41831326] Furlan R, Di Sapio A, Ferraro D, Rossi E Clin Chem Lab Med 2026 0
Role of astrocyte biomarker GFAP in early diagnosis and prognosis assessment of [PMID:41850459] Li S, Wei S, Wang L, Yu T, Wang H et al. Int J Biol Macromol 2026 0
Cerebral FURIN deficiency impairs astrocytic lipophagy through ITGAV maturation. [PMID:41376284] Unknown 0

Debates (4)

Multi-agent debates referencing this entity

How do gut microbiome-derived metabolites SCFAs LPS TMAO influence alpha-synucle

closed · Rounds: 4 · Score: 0.84 · 2026-04-16

How do alterations in brain lipid metabolism—including gangliosides, phospholipi

closed · Rounds: 4 · Score: 0.84 · 2026-04-11

Which metabolic biomarkers can distinguish therapeutic response from disease pro

closed · Rounds: 4 · Score: 0.92 · 2026-04-04

How does metabolic reprogramming (glucose metabolism shifts, brain insulin resis

closed · Rounds: 4 · Score: 0.73 · 2026-04-02